Adagia Partners, a pan-European mid-market private equity firm, announces the acquisition alongside the Schwind Family and management of Schwind eye-tech solutions GmbH (“Schwind”), one of the world’s leading specialists in laser systems for the treatment of vision defects and corneal diseases from Ardian.
Herter & Co. acted as Sole Debt Advisor to Adagia Partners on this transaction.
Founded in 1958, the company develops, produces, and distributes an extensive and highly sophisticated range of products. These include diagnostic tools and state-of-the-art laser systems for the treatment of vision defects and corneal diseases, as well as corresponding software solutions and services.
Worldwide, more than 1,300 SCHWIND laser systems are currently installed in ophthalmology practices, eye clinics, laser centers and university hospitals in over 100 countries. SCHWIND laser systems are used in LASIK, LASEK, PRK, TransPRK and Femto-LASIK eye surgery as well as in minimally invasive lenticle extraction. The combination of innovative technology and intelligent device design ensures maximum precision and safety in refractive corneal surgery. SCHWIND offers clients a one-step solution for the entire course of treatment, through an approach that encompasses the digital networking of diagnostic tools and eye laser systems, as well as other supplementary services.
The company has invested significantly in research and development in the last years. As a result, the product range, which previously consisted of various Excimer lasers and diagnostic devices, was expanded with a specially developed intelligent Femtosecond laser system (ATOS).
With the support of Adagia Partners, the management team’s ambition is to continue the growth of the Excimer activity and accelerate the global deployment of ATOS.
About Schwind
SCHWIND eye-tech-solutions is one of the technological leaders in the global market for refractive and therapeutic corneal surgery. The family business develops, produces, and markets a comprehensive, highly developed product portfolio for the treatment of vision defects and corneal diseases. With the SCHWIND AMARIS Excimer Laser product family and the SCHWIND ATOS femtosecond laser, the company covers the most important all-laser procedures of modern refractive surgery from a single source: the touch free TransPRK/SmartSurfACE surface treatment, intrastromal FemtoLASIK and minimally invasive SCHWIND SmartSight lenticle extraction of the new generation. Eye surgeons in more than 100 countries treat their patients with SCHWIND technologies.
About Adagia Partners
Adagia Partners is a pan-European mid-market private equity firm with offices in Frankfurt and Paris. The firm was created and is owned by its Partners. The team is made of 15 professionals with international and operational background. The firm is delivering performance for all stakeholders by fostering entrepreneurship and humanism.
Adagia Capital Europe, the €750m investment vehicle currently in fund raising, will be deployed in Midcap companies in France, Germany, Benelux, Switzerland and Austria. The fund has an industry specialist approach and focusses on Healthcare, Business Services and Tech Industries.
